The pharmaceutical industry is leading a great technological development, deeply impacted by the optimization of photonic technologies, which open a new range of possibilities and pharmaceutical treatments in continuous growth.

Upon the introduction in industry of the capability of manipulating chemical and biological elements with photons, new paths of pharmaceutical treatments have been opened with important advantages in terms of specificity and efficiency. For instance, the introduction of the laser became a turning point in the development of the pharmaceutical sector, as it provides all the benefits of a minimally invasive, customizable, specific and efficient performance. We find it in direct treatments with the patient, in the pharmaceutical research and innovation sector, and becoming an integral part of the manufacturing process.

We can also observe the direct impact of photonics in the overcoming of other very present challenges in the pharmaceutical industry, such as the detection of impurities and substance analysis, the marking of products for a correct serialization or improved control over correct drug administration. In this last section, there are already industrialized examples such as laser micromachining, which allows the molding of microneedles for the production of transdermal microinjection patches.

In short, the pharmaceutical sector is increasingly facing challenges of quality, biocompatibility and efficiency, as well as needing to maintain control over the costs of its services. Photonic technologies take on, then, the main role when it comes to improving the functionality of the sector’s capabilities, in addition to allowing different ways of research, innovation and development.

18 Socios expertos en este sector